Wnt/β-catenin signalling in adrenal physiology and tumour development

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · see citing works

Gene Silencing in Cancer in Association with Promoter Hypermethylation

Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,414 · see citing works

β‐catenin is a target for the ubiquitin–proteasome pathway

Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,533 · see citing works

Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism

Liu, C., Li, Y., Semënov, M. V., Han, C., Baeg, G., Tan, Y., Zhang, Z., Lin, X., & He, X. (2002) · Cell · doi:10.1016/s0092-8674(02)00685-2 · Cited by 2,066 · see citing works

A new member of the frizzled family from Drosophila functions as a Wingless receptor

Bhanot, P., van den Brink, M. R. M., Samos, C. H., Hsieh, J.-C., Wang, Y., Macke, J. P., Andrew, D. J., Nathans, J., & Nusse, R. (1996) · Nature · doi:10.1038/382225a0 · Cited by 1,504 · see citing works

GSK3 takes centre stage more than 20 years after its discovery

FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433 · see citing works

Williams Textbook of Endocrinology

Stoffer, S. S. (1999) · JAMA · doi:10.1001/jama.281.9.851 · Cited by 1,260 · see citing works

Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex

Kirschner, L. S., Carney, J. A., Pack, S. D., Taymans, S. E., Giatzakis, C., Cho, Y. S., Cho-Chung, Y. S., & Stratakis, C. A. (2000) · Nature Genetics · doi:10.1038/79238 · Cited by 1,153 · see citing works

Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer

Suzuki, H., Watkins, D. N., Jair, K.-W., Schuebel, K. E., Markowitz, S. D., Chen, W. D., Pretlow, T. P., Yang, B., Akiyama, Y., van Engeland, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1330 · Cited by 1,070 · see citing works

Function and biological roles of the Dickkopf family of Wnt modulators

Niehrs, C. (2006) · Oncogene · doi:10.1038/sj.onc.1210054 · Cited by 995 · see citing works

Management of the clinically inapparent adrenal mass ("incidentaloma")

Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00013 · Cited by 945 · see citing works

Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A

Fang, X., Yu, S. X., Lu, Y., Bast, R. C., Woodgett, J. R., & Mills, G. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220413597 · Cited by 833 · see citing works

Phosphorylation of β-Catenin by AKT Promotes β-Catenin Transcriptional Activity*

Fang, D.-X., Hawke, D., Zheng, Y., Xia, Y., Meisenhelder, J., Nika, H., Mills, G., Kobayashi, R., Hunter, T., & Lu, Z. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611871200 · Cited by 774 · see citing works

Drosophila Tcf and Groucho interact to repress Wingless signalling activity

Cavallo, R. A., Cox, R. T., Moline, M. M., Roose, J., Polevoy, G. A., Clevers, H., Peifer, M., & Bejsovec, A. (1998) · Nature · doi:10.1038/26982 · Cited by 730 · see citing works

Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy

Luton, J.-P., Cerdas, S., Billaud, L., Thomas, G., Guilhaume, B., Bertagna, X., Laudat, M.-H., Louvel, A., Chapuis, Y., Blondeau, P., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004263221705 · Cited by 717 · see citing works

Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease

Bovolenta, P., Esteve, P., Ruiz, J. M., Cisneros, E., & López-Rı́os, J. (2008) · Journal of Cell Science · doi:10.1242/jcs.026096 · Cited by 655 · see citing works

Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin

Ding, Q., Xia, W., Liu, J.-C., Yang, J.-Y., Lee, D.-F., Xia, J., Bartholomeusz, G., Li, Y., Pan, Y., Li, Z., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.009 · Cited by 597 · see citing works

Regulation of LEF-1/TCF transcription factors by Wnt and other signals.

Eastman, Q., & Grosschedl, R. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80031-3 · Cited by 571 · see citing works

Mutations of <i>β-Catenin</i> in Adrenocortical Tumors: Activation of the Wnt Signaling Pathway Is a Frequent Event in both Benign and Malignant Adrenocortical Tumors

Tissier, F., Cavard, C., Groussin, L., Perlemoine, K., Fumey, G., Hagneré, A.-M., René-Corail, F., Jullian, E., Gicquel, C., Bertagna, X., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0593 · Cited by 474 · see citing works

A frizzled homolog functions in a vertebrate Wnt signaling pathway

Yang-Snyder, J., Miller, J. R., Brown, J. D., Lai, C.-J., & Moon, R. T. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70716-1 · Cited by 469 · see citing works

Phosphorylation of β-Catenin by Cyclic AMP-dependent Protein Kinase

Taurin, S., Sandbo, N. K., Qin, Y., Browning, D. D., & Dulin, N. O. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508778200 · Cited by 450 · see citing works

Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients

Abiven, G., Coste, J., Groussin, L., Anract, P., Tissier, F., Legmann, P., Dousset, B., Bertagna, X., & Bertherat, J. (2006) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2005-2730 · Cited by 435 · see citing works

Phosphorylation of β-Catenin by Cyclic AMP-Dependent Protein Kinase Stabilizes β-Catenin through Inhibition of Its Ubiquitination

Hino, S., Tanji, C., Nakayama, K. I., & Kikuchi, A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.20.9063-9072.2005 · Cited by 428 · see citing works

Adrenocortical carcinoma: diagnosis, evaluation and treatment

NG, L., & LIBERTINO, J. M. (2003) · Journal of Urology · doi:10.1016/s0022-5347(05)64023-2 · Cited by 423 · see citing works

Adrenal cortical carcinoma

Dackiw, A. P. B., Lee, J. E., Gagel, R. F., & Evans, D. B. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0030-7 · Cited by 390 · see citing works

Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis

Giordano, T. J., Thomas, D. G., Kuick, R., Lizyness, M., Misek, D. E., Smith, A. L., Sanders, D., Aljundi, R. T., Gauger, P. G., Thompson, N. W., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63846-1 · Cited by 383 · see citing works

Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival

de Reyniès, A., Assié, G., Rickman, D. S., Tissier, F., Groussin, L., René-Corail, F., Dousset, B., Bertagna, X., Clauser, E., & Bertherat, J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.5678 · Cited by 382 · see citing works

A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia

Horvath, A., Boikos, S., Giatzakis, C., Robinson-White, A., Groussin, L., Griffin, K. J., Stein, E., Levine, E., Delimpasi, G., Hsiao, H. P., et al. (2006) · Nature Genetics · doi:10.1038/ng1809 · Cited by 352 · see citing works

Adrenocortical Carcinoma: Diagnosis, Evaluation and Treatment

NG, L., & LIBERTINO, J. M. (2003) · The Journal of Urology · doi:10.1097/00005392-200301000-00003 · Cited by 330 · see citing works

Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.

Gicquel, C., BERTAGNA, X. Y., Gaston, V., Coste, J., Louvel, A., Baudin, É., Bertherat, J. Y., Chapuis, Y., Duclos, J. M., Schlumberger, M. J., et al. (2001) · PubMed · Cited by 285 · see citing works

Adrenocortical cancer: pathophysiology and clinical management

Libé, R., Fratticci, A., & Bertherat, J. Y. (2007) · Endocrine Related Cancer · doi:10.1677/erc.1.01130 · Cited by 271 · see citing works

SERKAL Syndrome: An Autosomal-Recessive Disorder Caused by a Loss-of-Function Mutation in WNT4

Mandel, H., Shemer, R., Borochowitz, Z. U., Okopnik, M., Knopf, C. F., Indelman, M., Drugan, A., Tiosano, D., Gershoni‐Baruch, R., Choder, M., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.08.005 · Cited by 267 · see citing works

IGF-II induces rapid β-catenin relocation to the nucleus during epithelium to mesenchyme transition

Morali, O. G., Delmas, V., Moore, R. H., Jeanney, C., Thiery, J. P., & Larue, L. (2001) · Oncogene · doi:10.1038/sj.onc.1204660 · Cited by 264 · see citing works

Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy

de Fraipont, F., El Atifi, M., Cherradi, N., Le Moigne, G., Defaye, G., Houlgatte, R., Bertherat, J., Bertagna, X., Plouin, P.-F., Baudin, E., et al. (2005) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2004-1075 · Cited by 261 · see citing works

Tumor formation by genetic mutations in the components of the Wnt signaling pathway

Kikuchi, A. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01424.x · Cited by 258 · see citing works

HeterozygousMen1Mutant Mice Develop a Range of Endocrine Tumors Mimicking Multiple Endocrine Neoplasia Type 1

Bertolino, P., Tong, W., Galendo, D., Wang, Z., & Zhang, C. X. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0154 · Cited by 255 · see citing works

Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.

Bertherat, J. Y., Groussin, L., Sandrini, F., Matyakhina, L., Bei, T. A., Stergiopoulos, S. G., Papageorgiou, T., Bourdeau, I., Kirschner, L. S., Vincent-Dejean, C., et al. (2003) · PubMed · Cited by 250 · see citing works

Constitutive β-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development

Berthon, A. S., Sahut‐Barnola, I., Lambert-Langlais, S., de Joussineau, C., Damon‐Soubeyrand, C., Louiset, E., Taketo, M. M., Tissier, F., Bertherat, J. Y., Lefrançois‐Martinez, A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq029 · Cited by 239 · see citing works

β-Catenin and Hedgehog Signal Strength Can Specify Number and Location of Hair Follicles in Adult Epidermis without Recruitment of Bulge Stem Cells

Silva-Vargas, V., Celso, C. L., Giangreco, A., Ofstad, T. A., Prowse, D. M., Braun, K. M., & Watt, F. M. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.04.013 · Cited by 237 · see citing works

Wnt-4 Deficiency Alters Mouse Adrenal Cortex Function, Reducing Aldosterone Production

Heikkilä, M. M., Peltoketo, H., Leppäluoto, J., Ilves, M., Vuolteenaho, O. J., & Vainio, S. J. (2002) · Endocrinology · doi:10.1210/en.2002-220275 · Cited by 235 · see citing works

Shh signaling regulates adrenocortical development and identifies progenitors of steroidogenic lineages

King, P., Paul, A., & Laufer, E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909471106 · Cited by 220 · see citing works

Management of adrenocortical carcinoma

Allolio, B., Hahner, S., Weismann, D., & Fassnacht, M. (2004) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01881.x · Cited by 214 · see citing works

Structural and Functional Abnormalities at 11p15 Are Associated with the Malignant Phenotype in Sporadic Adrenocortical Tumors: Study on a Series of 82 Tumors1

Gicquel, C., Raffin‐Sanson, M., Gaston, V., BERTAGNA, X. Y., Plouin, P., Schlumberger, M. J., Louvel, A., LUTON, J. P., & Bouc, Y. L. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4170 · Cited by 213 · see citing works

Minireview: PRKAR1A: Normal and Abnormal Functions

Bossis, I., & Stratakis, C. A. (2004) · Endocrinology · doi:10.1210/en.2004-0900 · Cited by 204 · see citing works

Targeted disruption of β-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex

Kim, A. C., Reuter, A. L., Zubair, M., Else, T., Serecky, K., Bingham, N. C., Lavery, G. G., Parker, K. L., & Hammer, G. D. (2008) · Development · doi:10.1242/dev.021493 · Cited by 202 · see citing works

Expression of Frzb/Secreted Frizzled-Related Protein 3, a Secreted Wnt Antagonist, in Human Androgen-Independent Prostate Cancer PC-3 Cells Suppresses Tumor Growth and Cellular Invasiveness

Zi, X., Guo, Y., Simoneau, A. R., Hope, C., Xie, J., Holcombe, R. F., & Hoang, B. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0103 · Cited by 196 · see citing works

Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/β-catenin signaling

Yang, S. H., Andl, T., Grachtchouk, V., Wang, A., Liu, J., Syu, L.-J., Ferris, J., Wang, T. S., Glick, A. B., Millar, S. E., et al. (2008) · Nature Genetics · doi:10.1038/ng.192 · Cited by 195 · see citing works

Molecular Analysis of the Cyclic AMP-Dependent Protein Kinase A (PKA) Regulatory Subunit 1A (PRKAR1A) Gene in Patients with Carney Complex and Primary Pigmented Nodular Adrenocortical Disease (PPNAD) Reveals Novel Mutations and Clues For Pathophysiology: Augmented PKA Signaling is Associated with Adrenal Tumorigenesis in PPNAD

Groussin, L., Kirschner, L. S., Vincent-Dejean, C., Perlemoine, K., Jullian, E. H., Delemer, B., Zacharieva, S., Pignatelli, D., Carney, J. A., LUTON, J. P., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/344579 · Cited by 192 · see citing works

Structural and Functional Abnormalities at 11p15 Are Associated with the Malignant Phenotype in Sporadic Adrenocortical Tumors: Study on a Series of 82 Tumors

Gicquel, C. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.8.2559 · Cited by 186 · see citing works

Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells

Onganer, P. U., Kawano, Y., Caro, M., Walker, M. M., Diez, S., Darrington, R. S., Waxman, J., & Kypta, R. M. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-55 · Cited by 172 · see citing works

Molecular genetics of adrenocortical tumours, from familial to sporadic diseases

Libé, R., & Bertherat, J. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02004 · Cited by 168 · see citing works

Frequent mutations of <i>β‐catenin</i> gene in sporadic secreting adrenocortical adenomas*

Tadjine, M., Lampron, A., Ouadi, L., & Bourdeau, I. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03033.x · Cited by 153 · see citing works

Transcriptome analysis reveals that p53 and β-catenin alterations occur in a group of aggressive adrenocortical cancers

Ragazzon, B., Libé, R., Gaujoux, S., Assié, G., Fratticci, A., Launay, P., Clauser, E., Bertagna, X., Tissier, F., de Reyniès, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2014 · Cited by 152 · see citing works

Aberrant G‐protein coupled receptor expression in relation to adrenocortical overfunction

Lacroix, A., Bourdeau, I., Lampron, A., Mazzuco, T. L., Tremblay, J., & Hamet, P. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03689.x · Cited by 146 · see citing works

β-Catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma

Gaujoux, S., Grabar, S., Fassnacht, M., Ragazzon, B., Launay, P., Libé, R., Chokri, I., Audebourg, A., Royer, B., Sbiera, S., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2006 · Cited by 146 · see citing works

Dkk3 , downregulated in cervical cancer, functions as a negative regulator of β‐catenin

Lee, E., Jo, M., Rho, S. B., Park, K., Yoo, Y., Park, J., Chae, M., Zhang, W., & Lee, J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23913 · Cited by 144 · see citing works

Multiple Mechanisms for Wnt11-mediated Repression of the Canonical Wnt Signaling Pathway

Maye, P. F., Zheng, J., Li, L., & Wu, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311724200 · Cited by 143 · see citing works

Wnt/β-catenin and 3′,5′-cyclic adenosine 5′-monophosphate/protein kinase A signaling pathways alterations and somatic β-catenin gene mutations in the progression of adrenocortical tumors

Gaujoux, S., Tissier, F., Groussin, L., Libé, R., Ragazzon, B., Launay, P., Audebourg, A., Dousset, B., Bertagna, X., & Bertherat, J. (2008) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2008-0631 · Cited by 142 · see citing works

Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors

Bonnet, S., Gaujoux, S., Launay, P., Baudry, C., Chokri, I., Ragazzon, B., Libé, R., René-Corail, F., Audebourg, A., Vacher-Lavenu, M.-C., et al. (2011) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2010-1885 · Cited by 133 · see citing works

Isolation, characterisation and embryonic expression of WNT11, a gene which maps to 11q13.5 and has possible roles in the development of skeleton, kidney and lung

Lako, M., Strachan, T., Bullen, P., Wilson, D. I., Robson, S. C., & Lindsay, S. (1998) · Gene · doi:10.1016/s0378-1119(98)00393-x · Cited by 131 · see citing works

Gene array analysis of macronodular adrenal hyperplasia confirms clinical heterogeneity and identifies several candidate genes as molecular mediators

Bourdeau, I., Antonini, S. R. R., Lacroix, A., Kirschner, L. S., Matyakhina, L., Lorang, D., Libutti, S. K., & Stratakis, C. A. (2004) · Oncogene · doi:10.1038/sj.onc.1207277 · Cited by 130 · see citing works

Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes

Ugolini, F., Adélaı̈de, J., Charafe‐Jauffret, E., Nguyen, C., Jacquemier, J. D., Jordan, B., Birnbaum, D., & Pébusque, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202739 · Cited by 124 · see citing works

FGF‐2 modulates Wnt signaling in undifferentiated hESC and iPS cells through activated PI3‐K/GSK3β signaling

Ding, V., Ling, L., Natarajan, S., Yap, M. G. S., Cool, S. M., & Choo, A. B. H. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22214 · Cited by 122 · see citing works

Inactivation of theAPCGene Is Constant in Adrenocortical Tumors from Patients with Familial Adenomatous Polyposis but Not Frequent in Sporadic Adrenocortical Cancers

Gaujoux, S., Pinson, S., Gimenez‐Roqueplo, A., Amar, L., Ragazzon, B., Launay, P., Méatchi, T., Libé, R., BERTAGNA, X. Y., Audebourg, A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1497 · Cited by 121 · see citing works

Cushing's Syndrome and Fetal Features Resurgence in Adrenal Cortex–Specific Prkar1a Knockout Mice

Sahut‐Barnola, I., de Joussineau, C., Val, P., Lambert-Langlais, S., Damon‐Soubeyrand, C., Lefrançois‐Martinez, A., Pointud, J., Marceau, G., Sapin, V., Tissier, F., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000980 · Cited by 118 · see citing works

Nuclear-Cytoplasmic Shuttling of Menin Regulates Nuclear Translocation of β-Catenin

Cao, Y., Liu, R., Jiang, X., Lu, J., Jiang, J., Zhang, C. X., Li, X., & Ning, G. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00335-09 · Cited by 116 · see citing works

Analysis of Wnt Gene Expression in Prostate Cancer

Zhu, H., Mazor, M., Kawano, Y., Walker, M. M., Leung, H. Y., Armstrong, K., Waxman, J., & Kypta, R. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2704 · Cited by 115 · see citing works

Adrenal masses in patients with familial adenomatous polyposis

Marchesa, P., Fazio, V. W., Church, J. M., & McGannon, E. A. (1997) · Diseases of the Colon & Rectum · doi:10.1007/bf02050923 · Cited by 113 · see citing works

Characterisation of the phosphorylation of β-catenin at the GSK-3 priming site Ser45

Hagen, T., & Vidal‐Puig, A. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00485-0 · Cited by 110 · see citing works

Detection of somatic β-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD)

Tadjine, M., Lampron, A., Ouadi, L., Horvath, A., Stratakis, C. A., & Bourdeau, I. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03273.x · Cited by 108 · see citing works

Large Deletions of the PRKAR1A Gene in Carney Complex

Horvath, A., Bossis, I., Giatzakis, C., Levine, E., Weinberg, F. D., Meoli, E., Robinson-White, A. J., Siegel, J., Soni, P., Groussin, L., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1155 · Cited by 106 · see citing works

Analysis of Dickkopf3 interactions with Wnt signaling receptors

Nakamura, R. E. I., & Hackam, A. S. (2010) · Growth Factors · doi:10.3109/08977191003738832 · Cited by 105 · see citing works

Generation and Characterization of dickkopf3 Mutant Mice

Barrantes, I. D. B., Montero‐Pedrazuela, A., Guadaño‐Ferraz, A., Obregón, M.-J., de Mena, R. M., Gailus‐Durner, V., Fuchs, H., Franz, T. J., Kalaydjiev, S., Klempt, M., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2317-2326.2006 · Cited by 98 · see citing works

Identification of two novel activities of the Wnt signaling regulator Dickkopf 3 and characterization of its expression in the mouse retina

Nakamura, R. E. I., Hunter, D. D., Yi, H., Brunken, W. J., & Hackam, A. S. (2007) · BMC Cell Biology · doi:10.1186/1471-2121-8-52 · Cited by 94 · see citing works

Adrenal masses are associated with familial adenomatous polyposis

Smith, T. G. P. J., Clark, S. K., Katz, D. E., Reznek, R. H., & Phillips, R. K. S. (2000) · Diseases of the Colon & Rectum · doi:10.1007/bf02236860 · Cited by 94 · see citing works

Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus

Beckers, A. M., Abs, R., Willems, P. J., der Auwera, B. J. R. V., Kovács, K., Reznik, M., & Stevenaert, A. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.2.1639957 · Cited by 94 · see citing works

The T cell factor/β-Catenin Antagonist PKF115–584 Inhibits Proliferation of Adrenocortical Carcinoma Cells

Doghman, M., Cazareth, J., & Lalli, E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0247 · Cited by 90 · see citing works

Phosphorylation of β-catenin by PKA promotes ATP-induced proliferation of vascular smooth muscle cells

Taurin, S., Sandbo, N. K., Yau, D. M., Sethakorn, N., & Dulin, N. O. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00096.2008 · Cited by 87 · see citing works

Noncanonical Wnt11 Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration

Toyama, T., Lee, H. C., Koga, H., Wands, J. R., & Kim, M. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0238 · Cited by 78 · see citing works

Insights from Studies with Oral Cleft Genes Suggest Associations between WNT-pathway Genes and Risk of Oral Cancer

Filho, P. A. A., Letra, A., Cramer, A., et al. (2011) · Journal of Dental Research · doi:10.1177/0022034511401622 · Cited by 77 · see citing works

MicroRNA Signature of Primary Pigmented Nodular Adrenocortical Disease: Clinical Correlations and Regulation of Wnt Signaling

Iliopoulos, D., Bimpaki, E. I., Nesterova, M., & Stratakis, C. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0155 · Cited by 75 · see citing works

REIC/Dkk-3 induces cell death in human malignant glioma

Mizobuchi, Y., Matsuzaki, K., Kuwayama, K., Kitazato, K. T., Mure, H., Kageji, T., & Nagahiro, S. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-016 · Cited by 74 · see citing works

17q22–24 Chromosomal Losses and Alterations of Protein Kinase A Subunit Expression and Activity in Adrenocorticotropin-Independent Macronodular Adrenal Hyperplasia

Bourdeau, I., Matyakhina, L., Stergiopoulos, S. G., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2608 · Cited by 64 · see citing works

Adrenal adenomas in a patient with Gardner's syndrome

Naylor, E. W., & Gardner, E. I. (1981) · Clinical Genetics · doi:10.1111/j.1399-0004.1981.tb01810.x · Cited by 63 · see citing works

Solid tumors associated with multiple endocrine neoplasias

Almeida, M. Q., & Stratakis, C. A. (2010) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2010.09.006 · Cited by 63 · see citing works

β‐catenin abnormalities and associated insulin‐like growth factor overexpression are important in phyllodes tumours and fibroadenomas of the breast

Sawyer, E. J., Hanby, A. M., Poulsom, R., et al. (2003) · The Journal of Pathology · doi:10.1002/path.1391 · Cited by 62 · see citing works

β-Catenin Is Involved in Insulin-Like Growth Factor 1-Mediated Transactivation of the Androgen Receptor

Verras, M., & Sun, Z. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0208 · Cited by 62 · see citing works

Serial Analysis of Gene Expression in Adrenocortical Hyperplasia Caused by a GermlinePRKAR1AMutation

Horvath, A., Mathyakina, L., Vong, Q. P., Baxendale, V. J., Pang, A. L., Chan, W., & Stratakis, C. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1301 · Cited by 60 · see citing works

Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53+/− or Rb1+/− backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signaling

Almeida, M. Q., Muchow, M., Boikos, S. A., Bauer, A. J., Griffin, K., Tsang, K. M., Cheadle, C., Watkins, T., Wen, F., Starost, M. F., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq014 · Cited by 59 · see citing works

Zonal expression of dickkopf-3 and components of the Wnt signalling pathways in the human adrenal cortex

Suwa, T., Chen, M., Hawks, C., & Hornsby, P. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1780149 · Cited by 59 · see citing works

Systematic Analysis of G Protein-Coupled Receptor Gene Expression in Adrenocorticotropin-Independent Macronodular Adrenocortical Hyperplasia Identifies Novel Targets for Pharmacological Control of Adrenal Cushing’s Syndrome

Assié, G., Louiset, E., Stürm, N., René-Corail, F., Groussin, L., Bertherat, J. Y., Thomas, M., Lefèbvre, H., Feige, J., Clauser, É., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2281 · Cited by 57 · see citing works

Embryonic hair follicle fate change by augmented β-catenin through Shh and Bmp signaling

Suzuki, K., Yamaguchi, Y., Villacorte-Tabelin, M., Mihara, K., Akiyama, M., Shimizu, H., Taketo, M. M., Nakagata, N., Tsukiyama, T., Yamaguchi, T. P., et al. (2009) · Development · doi:10.1242/dev.021295 · Cited by 56 · see citing works

Adrenal Gland Tumorigenesis after Gonadectomy in Mice Is a Complex Genetic Trait Driven by Epistatic Loci

Bernichtein, S., Petretto, E. G., Jamieson, S., Goel, A., Aitman, T. J., Mangion, J., & Huhtaniemi, I. T. (2007) · Endocrinology · doi:10.1210/en.2007-0925 · Cited by 52 · see citing works

Expression of secreted frizzled related protein 1, a Wnt antagonist, in brain, kidney, and skeleton is dispensable for normal embryonic development

Trevant, B., Gaur, T., Hussain, S., Symons, J., Komm, B. S., Bodine, P. V. N., Stein, G. S., & Lian, J. B. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21482 · Cited by 51 · see citing works

Complete Sequencing and Messenger Ribonucleic Acid Expression Analysis of the MEN I Gene in Adrenal Cancer1

Schulte, K., Mengel, M., Heinze, M., Simon, D., Scheuring, S., Köhrer, K., & Röher, H. D. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6312 · Cited by 50 · see citing works

Adrenocortical tumor in a patient with familial adenomatous polyposis: a case associated with a complete inactivating mutation of the APC gene and unusual histological features

Wakatsuki, S., Sasano, H., Matsui, T., Nagashima, K., Toyota, T., & Horii, A. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90052-1 · Cited by 49 · see citing works

Adrenocorticotropin-Independent Macronodular Adrenocortical Hyperplasia Associated with Multiple Colon Adenomas/Carcinomas Which Showed a Point Mutation in the APC Gene.

Yamakita, N., Murai, T., Ito, Y., Miura, K., Ikeda, T., MIYAMOTO, K., ONAMI, S., & Yoshida, T. (1997) · Internal Medicine · doi:10.2169/internalmedicine.36.536 · Cited by 49 · see citing works

Menin dynamics and functional insight: Take your partners

Balogh, K., Patócs, A., Hunyady, L., et al. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.04.011 · Cited by 46 · see citing works

Wnt-11 signaling leads to down-regulation of the Wnt/β-catenin, JNK/AP-1 and NF-κB pathways and promotes viability in the CHO-K1 cells

Railo, A., Nagy, I., Kilpeläinen, P., & Vainio, S. J. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.04.010 · Cited by 43 · see citing works

Complete Sequencing and Messenger Ribonucleic Acid Expression Analysis of the MEN I Gene in Adrenal Cancer

Schulte, K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.1.441 · Cited by 43 · see citing works

Adenovirus-delivered DKK3/WNT4 and Steroidogenesis in Primary Cultures of Adrenocortical Cells

Chen, M., & Hornsby, P. J. (2006) · Hormone and Metabolic Research · doi:10.1055/s-2006-950500 · Cited by 35 · see citing works

Genetic Ablation of Sfrp4 in Mice Does Not Affect Serum Phosphate Homeostasis

Christov, M., Koren, S., Yuan, Q., Baron, R., & Lanske, B. (2011) · Endocrinology · doi:10.1210/en.2010-1351 · Cited by 33 · see citing works

Gβγ-mediated Prostacyclin Production and cAMP-dependent Protein Kinase Activation by Endothelin-1 Promotes Vascular Smooth Muscle Cell Hypertrophy through Inhibition of Glycogen Synthase Kinase-3

Taurin, S., Hogarth, K. D., Sandbo, N. K., Yau, D. M., & Dulin, N. O. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702655200 · Cited by 33 · see citing works

Expression of the Wnt antagonist DKK3 is frequently suppressed in sporadic epithelial ovarian cancer

You, A. B., Fokas, E., Wang, L., He, H., Kleb, B., Niederacher, D., Engenhart‐Cabillic, R., & An, H. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0916-6 · Cited by 32 · see citing works

Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors

Zwermann, O., Beuschlein, F., Mora, P., Weber, G., Allolio, B., & Reincke, M. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420689 · Cited by 30 · see citing works

Familial adenomatous polyposis associated with multiple adrenal adenomas in a patient with a rare 3′ APC mutation

Kartheuser, A. H., Walon, C., West, S. L., Breukel, C., Detry, R. J., Gribomont, A.-C., Hamzehloei, T., Hoang, P., Maiter, D. M., Pringot, J., et al. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.1.65 · Cited by 29 · see citing works

Cortisol Producing Adrenal Adenoma—a New Manifestation of Gardner's Syndrome

Beuschlein, F., Reincke, M., Königer, M., D'Orazio, D., Dobbie, Z., & Rump, L. C. (2000) · Endocrine Research · doi:10.3109/07435800009048600 · Cited by 27 · see citing works

MEN I gene mutations in sporadic adrenal adenomas

Schulte, K., Heinze, M., Simon, D., Scheuring, S., K�hrer, K., R�her, H.-D., & Mengel, M. (1999) · Human Genetics · doi:10.1007/s004399900193 · Cited by 23 · see citing works

WNT-4mRNA Expression in Human Adrenocortical Tumors and Cultured Adrenal Cells

Kuulasmaa, T., Jääskeläinen, J., Suppola, S., et al. (2008) · Hormone and Metabolic Research · doi:10.1055/s-2008-1078716 · Cited by 14 · see citing works

Adrenal Adenoma in a Patient with Gardner's Syndrome. A case report

Chelaifa, K., Bouzaïdi, K., Chouaïb, S., Azaiz, O., Messaoud, M. B., & Slim, R. (2003) · Acta Radiologica · doi:10.1034/j.1600-0455.2003.00039.x · Cited by 14 · see citing works

Primary Aldosteronism in a Patient With Familial Adenomatous Polyposis

Alexander, G. L., Thompson, G. B., & Schwartz, D. A. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.6.636 · Cited by 14 · see citing works

Familial desmoids in association with adrenal and ovarian masses and leiomyomas

Özüner, G., & Hull, T. L. (1999) · Diseases of the Colon & Rectum · doi:10.1007/bf02234182 · Cited by 13 · see citing works

The Transcriptome that Mediates Increased Cyclic Adenosine Monophosphate Signaling in Prkar1a Defects and Other Settings

Azevedo, M. F., & Stratakis, C. A. (2011) · Endocrine Practice · doi:10.4158/ep10412.ra · Cited by 12 · see citing works

Clinically Inapparent Adrenal Mass in a Patient with Familial Adenomatous Polyposis

Corrales, P. J. P., González-Albarrán, O., Peralta, M. G., Roa, C. M., & Antón, T. (2006) · Hormone Research in Paediatrics · doi:10.1159/000094742 · Cited by 9 · see citing works

Lack of mutations of exon 2 of the MEN1 gene in endocrine and nonendocrine sporadic tumors

Costa, S. C., Nascimento, L. S., Ferreira, F. J., et al. (2001) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2001000700004 · Cited by 5 · see citing works

Untitled work

Wajchenberg (2000) · doi:10.1002/(sici)1097-0142(20000215)88:4

Untitled work

Painter (1985) · doi:10.1002/1097-0142(19850501)55:9

Adrenocortical carcinoma

Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892 · see citing works

Activating hotspot L205R mutation in <i>PRKACA</i> and adrenal Cushing’s syndrome

Cao, Y., He, M., Gao, Z., Peng, Y., Li, Y., Li, L., Zhou, W., Li, X., Zhong, X., Lei, Y., et al. (2014) · Science · doi:10.1126/science.1249480 · Cited by 232 · see citing works

<i>ARMC5</i> Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences

Espiard, S., Drougat, L., Libé, R., Assié, G., Perlemoine, K., Guignat, L., Barrande, G., Brucker-Davis, F., Doullay, F., Lopez, S., et al. (2015) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2014-4204 · Cited by 196 · see citing works

<i>ARMC5</i>Mutations Are a Frequent Cause of Primary Macronodular Adrenal Hyperplasia

Alencar, G. A., Lerario, A. M., Nishi, M. Y., Mariani, B. M. D. P., Almeida, M. Q., Tremblay, J., Hamet, P., Bourdeau, I., Zerbini, M. C. N., Pereira, M. A. A., et al. (2014) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2013-4237 · Cited by 162 · see citing works

Adrenocortical zonation, renewal, and remodeling

Pihlajoki, M., Dörner, J., Cochran, R. S., Heikinheimo, M., & Wilson, D. B. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00027 · Cited by 114 · see citing works

60 YEARS OF POMC: Adrenal and extra-adrenal functions of ACTH

Gallo-Payet, N. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0257 · Cited by 98 · see citing works

Genetics of tumors of the adrenal cortex

Bonnet-Serrano, F., & Bertherat, J. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0361 · Cited by 80 · see citing works

Pathology of the adrenal cortex: a reappraisal of the past 25 years focusing on adrenal cortical tumors

Papotti, M., Duregon, E., Volante, M., & McNicol, A. M. (2014) · Endocrine Pathology · doi:10.1007/s12022-013-9291-6 · Cited by 33 · see citing works

Adrenocortical cancer and IGF2: is the game over or our experimental models limited?

Drelon, C., Berthon, A., & Val, P. (2013) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2012-3310 · Cited by 24 · see citing works

Context-Dependent Activation or Inhibition of Wnt-β-Catenin Signaling by Kremen

Cselenyi, C. S., & Lee, E. N. (2008) · Science Signaling · doi:10.1126/stke.18pe10 · Cited by 52 · see citing works

LDL receptor-related proteins 5 and 6 in Wnt/β-catenin signaling:Arrows point the way

He, X., Semenov, M., Tamai, K., & Zeng, X. (2004) · Development · doi:10.1242/dev.01117 · Cited by 1,044 · see citing works

Wnt-4 activates the canonical β-catenin-mediated Wnt pathway and binds Frizzled-6 CRD: functional implications of Wnt/β-catenin activity in kidney epithelial cells

Lyons, J. P., Mueller, U. W., Ji, H. L., Everett, C. M., Fang, X., Hsieh, J.-C., Barth, A. I. M., & McCrea, P. D. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.04.036 · Cited by 138 · see citing works

Wnt Isoform-Specific Interactions with Coreceptor Specify Inhibition or Potentiation of Signaling by LRP6 Antibodies

Gong, Y., Bourhis, E., Chiu, C., Stawicki, S. S., DeAlmeida, V. I., Liu, B. Y., Phamluong, K., Cao, T. C., Carano, R. A. D., Ernst, J. A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012682 · Cited by 206 · see citing works

LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells

Peröbner, I., Karow, M., Jochum, M., & Neth, P. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.07.025 · Cited by 24 · see citing works